PROTEOMICS - CLINICAL APPLICATIONSSystems BiologyPeer-reviewed journal article
Identification of protein abundance changes in biopsy-level hepatocellular carcinoma tissues using PCT-SWATH
Yi ZhuiD, Jiang ZhuiD, Cong LuiD, Qiushi ZhangiD, Wei XieiD, Ping SuniD, Xiaochuan Dong, Liang YueiD, Yaoting SuniD, Xiao YiiD, Tiansheng ZhuiD, Guan RuaniD, Ruedi H. AebersoldiD, Shiang HuangiD, Tiannan GuoiD
Abstract
In this study, we optimized the pressure-cycling technology (PCT) and SWATH mass spectrometry workflow to analyze biopsy-level tissue samples (2 mg wet weight) from 19 hepatocellular carcinoma (HCC) patients. Using OpenSWATH and pan-human spectral library, we quantified 11,787 proteotypic peptides from 2,579 SwissProt proteins in 76 HCC tissue samples within about 9 working days (from receiving tissue to SWATH data). The coefficient of variation (CV) of peptide yield using PCT was 32.9%, and the R2 of peptide quantification was 0.9729. We identified protein changes in malignant tissues compared to matched control samples in HCC patients, and further stratified patient samples into groups with high -fetoprotein (AFP) expression or HBV infection. In aggregate, the data identified 23 upregulated pathways and 13 ones. We observed enhanced biomolecule synthesis and suppressed small molecular metabolism in liver tumor tissues. 16 proteins of high documented relevance to HCC are highlighted in our data. We also identified changes of virus-infection-related proteins including PKM, CTPS1 and ALDOB in the HBV+ HCC subcohort. In conclusion, we demonstrate the practicality of performing proteomic analysis of biopsy-level tissue samples with PCT-SWATH methodology with moderate effort and within a relatively short timeframe.
- Citations
- 40
- FWCI
- 1.94
- Field percentile
- top 14%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cirrhosis severity modulates proteomic and immune landscapes in hepatocellular carcinoma
R. Shastry, Aditya P. Kale, Sui Seng Tee·npj gut and liver.Peer-reviewed·Sep 2, 2026
- High-throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification
- Proteomic profiling of advanced hepatocellular carcinoma identifies predictive signatures of response to treatments
Frédéric Saltel, Adèle Delamarre, … Anne-Aurélie Raymond·ESMO OpenPeer-reviewed·Sep 1, 2025
- Orthogonal proteomic platforms and their implications for the stable classification of high-grade serous ovarian cancer subtypes
S. N. Thomas, B. Friedrich, … R. Aebersold·bioRxiv·Oct 3, 2019
- Accelerated Protein Biomarker Discovery from FFPE tissue samples using Single-shot, Short Gradient Microflow SWATH MS
- dia-PASEF Proteomics of Tumor and Stroma LMD Enriched from Archived HNSCC Samples
Aswini Panigrahi, Allison L. Hunt, … Radoslav Goldman·ACS OmegaPeer-reviewed·Mar 25, 2025